Skip to Main Content

Special Report

From biotech innovations to health care industry profits, STAT Special Reports dive deep into developments that can shape industries and move markets. Our most-read stories include the impact of hospitals on climate change, the use of artificial intelligence in health care, a giant tobacco company providing financing for a pharmaceutical company and more.

Latest

Special Report Andrew Joseph

STAT Plus: Gene therapy makers wonder if they can make a profit in Europe. Patients fear being left behind — again

Special Report Eric Boodman

How a conservative, gun-toting doctor defended abortion access in Appalachia

Special Report Sadia Rafiquddin

No longer brushed off: A Minnesota clinic tries to rewrite medicine’s approach to miscarriage

Special Report Bob Herman, J. Emory Parker, Adam Feuerstein, Lizzy Lawrence and Mohana Ravindranath

STAT Plus: Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows

Special Report Usha Lee McFarling

Asian American doctors, overrepresented in medicine, are largely left out of leadership

Special Report Allison DeAngelis — STAT and Ryan Cross — The Boston Globe

STAT Plus: The inside story of how data integrity issues roiled a biotech seen as ‘Moderna 2.0’

Special Report Jonathan Wosen

Academia’s postdoc system is teetering, imperiling efforts to diversify life sciences

Special Report Lizzy Lawrence

STAT Plus: Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted in chronic pain patients

All Coverage

Special Report Brittany Trang

STAT Plus: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm

Special Report Lev Facher

STAT Plus: How the drug industry uses fear of fentanyl to extract more profit from naloxone

advertisement

The Obesity Revolution Elaine Chen and Matthew Herper

STAT Plus: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Special Report Jason Mast, Allison DeAngelis and Megan Molteni

STAT Plus: CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools

Special Report Mohana Ravindranath

STAT Plus: How Mindstrong’s rush to roll out a ‘smoke alarm’ for mental illness led to its downfall

Special Report Rosa Furneaux and Laura Margottini — TBIJ

STAT Plus: The drug was meant to save children’s lives. Instead, they’re dying

Special Report Jason Mast

STAT Plus: We finally have new drugs for sickle cell disease. Why are so few patients taking them?

Special Report Rachel Cohrs

STAT Plus: PhRMA, once invincible in Washington, has lost its edge

Special Report Jonathan Wosen

STAT Plus: ‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

Special Report Casey Ross

Microsoft’s note-taking tool asks doctors to make a grand bargain: Share patient data, and get your life back

Special Report Matthew Herper

Here’s why we’re not prepared for the next wave of biotech innovation

Special Report Tara Bannow and Bob Herman

STAT Plus: Private equity’s Welsh Carson, casting itself as a noble force, relentlessly pursues profits in health care

Special Report Karen Pennar

‘If I were a hospital, I’d be reading the tea leaves’: Pressures grow on the health care industry to reduce its climate pollution

Special Report Casey Ross

Epic’s overhaul of a flawed algorithm shows why AI oversight is a life-or-death issue

Special Report Sarah Owermohle

STAT Plus: A minuscule new HHS office has a mammoth goal: tackling environmental justice

Special Report Casey Ross and Mohana Ravindranath

STAT Plus: Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing

Special Report Olivia Goldhill

STAT Plus: Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison